Anticancer potential of (-)-epicatechin in a triple-negative mammary gland model.
Georgina AlmaguerPilar Ortiz-VilchisPaola CorderoRocío Martinez-VegaJavier Perez-DuránEduardo MeaneyFrancisco VillarrealGuillermo CeballosNayelli NajeraPublished in: The Journal of pharmacy and pharmacology (2022)
EC has antiproliferative properties and increases survival in a model of TNBC. These effects may occur through the modulation of deregulated AMPK and Akt/mTOR signalling pathways.